Regarding the unique therapeutic drug for neo-coronavirus pneumonia, it is not yet available. New pneumonia is a coronavirus infection, which is a new coronavirus, so no new drugs have been developed specifically for the new coronavirus. The drugs used in clinical practice are all marketed drugs, such as kleenex for AIDS, which is a protease inhibitor and can inhibit HIV replication. In some studies, it was found that Kratom may have inhibited SARS back then, and the Middle East Respiratory Syndrome found in 2012. In vitro tests have also found that Kratom has an inhibitory effect on coronavirus, so clinical attempts have been made to use Kratom in patients with novel coronavirus pneumonia. Other therapeutic drugs such as oseltamivir and Abidor for influenza and chloroquine phosphate for malaria are marketed drugs that have been used to try their effects on novel coronavirus pneumonia. In addition, the drug Ridciclovir, used in the United States for the treatment of Ebola, was considered to be more effective after treating a patient with new coronavirus pneumonia, and it is now also being used experimentally for the treatment of patients with new coronavirus, but no specific results are available. Content source: Dr. You Lai